Related Experiment Video
Updated: Jan 18, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Environmental sustainability considerations in the reporting of randomised clinical trials
Florien S van Royen1, Ewoud Schuit2
1Department of General Practice and Nursing Science, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Abstract:
Randomised clinical trials (RCTs) can contribute substantially to carbon dioxide emissions. In this Viewpoint, we explored the extent to which primary publications of RCTs reported environmental sustainability considerations in their study design (eg, resource use and travel movement) and outcomes (eg, the environmental impact of interventions under study). 252 RCTs published between Oct 17, 2022, and Oct 17, 2023, in five prominent medical journals, The Lancet, TheNew England Journal of Medicine, Nature Medicine, TheBritish Medical Journal, and PLOS Medicine, were included. Sustainability-related statements were reported in 29 (12%) of 252 of RCTs, but only four (1·6%) of 252 explicitly referenced sustainability considerations in their study design or outcome. Thus, environmental sustainability aspects of the study design decisions or outcomes collected seem to be rarely reported in primary publications of RCTs. The findings of this Viewpoint highlight the need for strategies for improved awareness of reporting of environmental sustainability considerations in the context of RCTs.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Blinding
Randomized Experiments
Simple randomization
Simple...
Bioavailability Study Design: Healthy Subjects Versus Patients

